Topics

New technique to identify a common cause to TMA diseases for which there is a treatment

19:00 EST 7 Nov 2019 | AAAS

(Josep Carreras Leukaemia Research Institute) Researchers have developed a technique that allows detecting an anomaly in the alternative pathway of the complement system, a part of our immune system that if deregulated can attack the patient's own endothelial cells and cause thrombotic microangiopathy (TMA), a severe injury common to a diversity of diseases. If the pathway is altered, the drug that is used for a syndrome with good prognostic could be used in other range of TMA-related diseases.

Original Article: New technique to identify a common cause to TMA diseases for which there is a treatment

NEXT ARTICLE

More From BioPortfolio on "New technique to identify a common cause to TMA diseases for which there is a treatment"

Quick Search

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...